Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

[Tourette Syndrome: Clinical Features and Pathophysiology].

Nomura Y.

Brain Nerve. 2017 Dec;69(12):1373-1385. doi: 10.11477/mf.1416200922. Japanese.

PMID:
29282341
2.

Aripiprazole in treatment of Gilles de la Tourette syndrome - New therapeutic option.

Janik P, Szejko N.

Neurol Neurochir Pol. 2018 Jan - Feb;52(1):84-87. doi: 10.1016/j.pjnns.2017.10.015. Epub 2017 Nov 9. Review.

PMID:
29154107
3.

Feasibility and Relevance of Antipsychotic Safety Monitoring in Children With Tourette Syndrome: A Prospective Longitudinal Study.

Pringsheim T, Ho J, Sarna JR, Hammer T, Patten S.

J Clin Psychopharmacol. 2017 Oct;37(5):498-504. doi: 10.1097/JCP.0000000000000760.

PMID:
28816926
4.

Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents.

Sallee F, Kohegyi E, Zhao J, McQuade R, Cox K, Sanchez R, van Beek A, Nyilas M, Carson W, Kurlan R.

J Child Adolesc Psychopharmacol. 2017 Nov;27(9):771-781. doi: 10.1089/cap.2016.0026. Epub 2017 Jul 7.

5.

Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.

Gerasch S, Kanaan AS, Jakubovski E, Müller-Vahl KR.

Front Neurosci. 2016 Sep 12;10:416. doi: 10.3389/fnins.2016.00416. eCollection 2016.

6.

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders.

Cox JH, Seri S, Cavanna AE.

Pediatric Health Med Ther. 2016 Jun 27;7:57-64. doi: 10.2147/PHMT.S87121. eCollection 2016. Review.

7.

The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.

Wang LJ, Chou WJ, Chou MC, Gau SS.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):442-8. doi: 10.1089/cap.2015.0104. Epub 2016 Mar 30.

PMID:
27028456
8.

Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Meta-Analysis.

Liu Y, Ni H, Wang C, Li L, Cheng Z, Weng Z.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):436-41. doi: 10.1089/cap.2015.0125. Epub 2016 Feb 25.

PMID:
26914764
9.

Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis.

Hollis C, Pennant M, Cuenca J, Glazebrook C, Kendall T, Whittington C, Stockton S, Larsson L, Bunton P, Dobson S, Groom M, Hedderly T, Heyman I, Jackson GM, Jackson S, Murphy T, Rickards H, Robertson M, Stern J.

Health Technol Assess. 2016 Jan;20(4):1-450, vii-viii. doi: 10.3310/hta20040. Review.

10.

Serial pharmacological prescribing practices for tic management in Tourette syndrome.

Farag M, Stern JS, Simmons H, Robertson MM.

Hum Psychopharmacol. 2015 Nov;30(6):435-41. doi: 10.1002/hup.2495. Epub 2015 Aug 24.

PMID:
26299248
11.

Exacerbation of tics after combining aripiprazole with pimozide: a case with Tourette Syndrome.

Mazlum B, Zaimoğlu S, Öztop DB.

J Clin Psychopharmacol. 2015 Jun;35(3):350-1. doi: 10.1097/JCP.0000000000000331. No abstract available.

PMID:
25928702
12.

Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study.

Cuenca J, Glazebrook C, Kendall T, Hedderly T, Heyman I, Jackson G, Murphy T, Rickards H, Robertson M, Stern J, Trayner P, Hollis C.

BMC Psychiatry. 2015 Mar 11;15:46. doi: 10.1186/s12888-015-0430-0.

13.

Adolescent with tourette syndrome and bipolar disorder: a case report.

Shim SH, Kwon YJ.

Clin Psychopharmacol Neurosci. 2014 Dec;12(3):235-9. doi: 10.9758/cpn.2014.12.3.235. Epub 2014 Dec 26.

14.

The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Budman CL.

Drugs. 2014 Jul;74(11):1177-93. doi: 10.1007/s40265-014-0254-0. Review.

PMID:
25034359
15.

Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.

Egolf A, Coffey BJ.

Drugs Today (Barc). 2014 Feb;50(2):159-79. doi: 10.1358/dot.2014.50.2.2097801. Review.

PMID:
24619591
16.

Emerging treatment strategies in Tourette syndrome: what's in the pipeline?

Termine C, Selvini C, Rossi G, Balottin U.

Int Rev Neurobiol. 2013;112:445-80. doi: 10.1016/B978-0-12-411546-0.00015-9. Review.

PMID:
24295630
17.

Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

Rizzo R, Gulisano M, Calì PV, Curatolo P.

Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Epub 2013 Mar 7. Review.

PMID:
23473832
18.

Pharmacological treatment of Gilles de la Tourette syndrome.

Hartmann A, Worbe Y.

Neurosci Biobehav Rev. 2013 Jul;37(6):1157-61. doi: 10.1016/j.neubiorev.2012.10.014. Epub 2012 Nov 5. Review.

PMID:
23137552
19.

Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.

Rizzo R, Eddy CM, Calí P, Gulisano M, Cavanna AE.

Pediatr Neurol. 2012 Dec;47(6):419-22. doi: 10.1016/j.pediatrneurol.2012.08.015.

PMID:
23127261
20.

Pharmacological treatment of tic disorders and Tourette Syndrome.

Roessner V, Schoenefeld K, Buse J, Bender S, Ehrlich S, Münchau A.

Neuropharmacology. 2013 May;68:143-9. doi: 10.1016/j.neuropharm.2012.05.043. Epub 2012 Jun 20. Review.

PMID:
22728760

Supplemental Content

Loading ...
Support Center